Following a clean corporate restructure, Alltorc Innovations Ltd has capitalised its patents, converted long-term director debt to equity, and moved into profit. The company is seeking a £75,000 business loan to complete the amalgamation and secure a positive opening balance sheet, ahead of a planned equity investment to carry the business through to sale.
Alltorc Innovations Ltd is a UK-based materials-technology company commercialising a portfolio of patented, clinically-relevant thermoplastic products. The group is built around flexiTorc®, a low-melt, reusable thermoplastic material protected by European Patent EP3107507 and already distributed internationally.
A patented (EP3107507), clinically validated low-melt reusable thermoplastic filament for orthotic and prosthetic applications, with worldwide manufacturing and distribution already in place.
A prosthetics innovation applying the flexiTorc® material to lower-limb prosthetic fitting — the focus of the group's clinical and investor programme.
A lightweight, re-usable, thermally-adjustable anti-stab protective sleeve for frontline workers, developed under a dedicated R&D programme.
Development to date has been funded by director personal loans exceeding £500,000, supplemented by business loans and R&D Tax Credit reclaims — demonstrating strong founder conviction.
A clean corporate restructure consolidates the group into a single entity, properly reflects the value of the intellectual property on the balance sheet, and converts long-term director debt into equity.
Alltorc Innovations Ltd established as the new consolidated holding entity for the group.
torc2 Ltd fully merged into Alltorc Innovations Ltd, simplifying the structure.
torcProtective Ltd becomes dormant under the new structure, reducing complexity.
All patent and trademark costs capitalised, properly reflecting IP value on the balance sheet.
Assignment of the European Patent and trademarks, plus the worldwide manufacturing, distribution and licence agreement with the flexiTorc® material manufacturer.
Long-term director loans converted from debt to equity — transforming the balance-sheet deficit.
Capitalising the patent and converting director loans to equity moves the business from a substantial net-liability position to positive net assets — the foundation for a fundable, saleable company.
Together with a move into profit this year, the restructure turns a company carrying net liabilities of over £600,000 into one with positive net assets — a materially stronger position from which to borrow, invest and grow.
The consolidated position is built on a substantial intangible asset and a trading business that is already in profit. The figures below cover the eight months to 30 June 2026 (profit & loss) and the position as at 30 June 2026 (balance sheet).
Income is led by technical consultancy (£23,218) and R&D Tax Credit reclaims (£14,915), with development finance directing working capital into the intellectual property. Turnover and profit shown are for the eight-month period; the patent and net-asset figures are as at 30 June 2026.
A £75,000 business loan secures the new company's footing: it repays existing loans, completes the corporate amalgamation cleanly, and retains working capital so Alltorc Innovations opens with a positive balance sheet.
Repay existing loans and complete the corporate amalgamation cleanly.
Ensure the restructuring is correct in accounting and legal terms — including patent and trademark migration to the new company name.
Retained to provide the new company with an initial positive balance sheet and operational runway.
The £75,000 loan does its job at the point it is drawn: it repays the existing borrowing, completes the amalgamation, and leaves Alltorc Innovations standing on a clean, positive balance sheet. It is the foundation, not the finish.
From there, the plan looks beyond the loan. With the restructure done and the intellectual property properly valued on the books, the company is in a position to bring in equity investment — money that first repays the £75,000 in full, then provides the working capital to carry a validated materials-technology business through to a planned sale.
With the restructure complete and the balance sheet in positive territory, Alltorc Innovations seeks equity investment to carry the validated business through to a planned sale.
From a maximum of two investors.
All existing shareholders retained.
The £150,000 investment first repays the £75,000 business loan used for restructuring.
The remaining balance provides working capital to carry Alltorc Innovations through to sale.
All existing shareholders retain their positions. Ron Taylor relinquishes 20% of his shareholding to enable this opportunity.
Alltorc Innovations is proud to be supported by the following universities and organisations.
Join us as we transform innovative materials technology into a globally scalable business.